Cipher Pharmaceuticals Inc. (CPH) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Bye. Thank you. Thank you. Thank you. Thank you. Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the CIFR Pharmaceuticals quarterly conference call for the company's Q1 2026 financial results. At this time, all participants are in a listen-only mode. Following today's presentation, instructions will be given for the question and answer session. If anyone needs assistance at any time during the call, you may press the star followed by the zero on your push-button phone. As a reminder, this conference is being recorded today, Friday, May 8, 2026. On behalf of the speakers that follow, listeners are cautioned that today's presentation and the responses to questions may contain forward-looking statements within the meaning of the safe harbor provisions of the Canadian Provincial Securities Laws. Forward-looking statements involve risks and uncertainties, and a jury line should not be placed on such statements. Certain material factors or assumptions are implied in making forwarded statements and actual results may differ materially from those expressed or implied in such statements. For additional information about factors that could cause results to vary, this refers to the risks identified in the company's annual information form and other filings with Canadian regulatory authorities. Except as required by Canadian securities laws, The company does not undertake to update any forward-looking statements. Such statements speak only as of the date made. I would like to turn the call over to Mr. Craig Moe, Interim Chief Executive Officer of the company. Please go ahead, Mr. Moe. Good morning, everyone, and thank you for joining us today. Before I begin, I'd like to remind everyone that all figures discussed on today's call are expressed in U.S. do...